Huge R&D advantage gives VRCI $.0128 a competitive
Post# of 29
http://www.stockpumpers.blogspot.com/2014/10/...juana.html
Harp Sangha, Verde's Chairman and CEO commented, "The addition of Drs. Jain to our current in-house R&D staff in Canada is going to be an immediate boost to our research program. It enables us to begin on research and clinical trials in India, which at the moment are on hold pending licensing in Canada. This gives Verde a huge advantage."